Pharmacokinetics of Nevirapine in HIV and Tuberculosis-coinfected Children Receiving Antiretroviral Fixed-dose Combination Tablets While Receiving Rifampicin-containing Tuberculosis Treatment and After Rifampicin Discontinuation

被引：6
|
作者：
Prasitsuebsai, Wasana
Cressey, Tim R. [2 ,3 ]
Capparelli, Edmund [4 ]
Vanprapar, Nirun
Lapphra, Keswadee
Chokephaibulkit, Kulkanya [1 ]
机构：
[1] Mahidol Univ, Siriraj Hosp, Div Infect Dis, Dept Pediat,Fac Med, Bangkok 10700, Thailand
[2] Chiang Mai Univ, Program HIV Prevent & Treatment IRD URI 174, Dept Med Technol, Fac Associated Med Sci, Chiang Mai 50000, Thailand
[3] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[4] Univ Calif San Diego, Dept Pediat Pharm & Drug Discovery, San Diego, CA 92103 USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2012年 / 31卷 / 04期
关键词：
HIV/TB coinfection; nevirapine; rifampicin; children; PLASMA-CONCENTRATIONS;
D O I：
10.1097/INF.0b013e3182401c41
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We assessed the pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children while they were receiving nevirapine-containing fixed-dose combination tablets with rifampicin-based tuberculosis treatment and after discontinuation. The median age (range) was 9.7 (4.4-11.7) years. The nevirapine area under the concentration versus time curve from 0 to 12 hours and trough concentration with rifampicin were 85.3 (40.5-170.7) mu g.h/mL and 6.4 (3.00-13.27) mu g/mL, respectively, providing adequate exposure.
引用
收藏
页码：389 / 391
页数：3
相关论文
共 16 条
  • [1] Estimate of the global market for rifampicin-containing fixed-dose combination tablets
    Norval, PY
    Blomberg, B
    Kitler, ME
    Dye, C
    Spinaci, S
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (11) : S292 - S300
  • [2] Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets
    Pollock, Louisa
    Else, Laura
    Poerksen, Goenke
    Molyneux, Elizabeth
    Moons, Peter
    Walker, Sarah
    Fraser, William
    Back, David
    Khoo, Saye
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (06) : 1251 - 1259
  • [3] Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine
    Chokephaibulkit, K
    Plipat, N
    Cressey, TR
    Frederix, K
    Phongsamart, W
    Capparelli, E
    Kolladarungkri, T
    Vanprapar, N
    AIDS, 2005, 19 (14) : 1495 - 1499
  • [4] Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment
    Bhatt, N. B.
    Barau, C.
    Amin, A.
    Baudin, E.
    Meggi, B.
    Silva, C.
    Furlan, V.
    Grinsztejn, B.
    Barrail-Tran, A.
    Bonnet, M.
    Taburet, A. M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (06) : 3182 - 3190
  • [5] Segregated Delivery of Rifampicin and Isoniazid from Fixed Dose Combination Bilayer Tablets for the Treatment of Tuberculosis
    Silva, A. M.
    Abrahim-Vieira, B.
    do Carmo, F. A.
    do Amaral, L. H.
    Silva, L. C.
    Escudini, C. S.
    Lopes, M. A.
    Sousa, V. P.
    Castro, H. C.
    Veiga, F.
    Rodrigues, C. R.
    Ribeiro, A. J.
    Cabral, L. M.
    BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 4 (14): : 1781 - 1801
  • [6] Pharmacokinetics and 48 Week Efficacy of Adjusted Dose Indinavir/Ritonavir in Rifampicin-Treated HIV/Tuberculosis-Coinfected Patients: A Pilot Study
    Avihingsanon, Anchalee
    van der Lugt, Jasper
    Singphore, Umaporn
    Gorowara, Meena
    Boyd, Mark
    Ananworanich, Jintanat
    Phanuphak, Praphan
    Burger, David
    Ruxrungtham, Kiat
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (10) : 1170 - 1176
  • [7] HEPATOTOXICITY IN PATIENTS CO-INFECTED WITH TUBERCULOSIS AND HIV-1 WHILE RECEIVING NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR-BASED ANTIRETROVIRAL THERAPY AND RIFAMPICIN-CONTAINING ANTI-TUBERCULOSIS REGIMEN
    Mankhatitham, Wiroj
    Lueangniyomkul, Aroon
    Manosuthi, Weerawat
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (03) : 651 - 658
  • [8] Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens
    Scarsi, Kimberly K.
    Smeaton, Laura M.
    Podany, Anthony T.
    Olefsky, Maxine
    Woolley, Elizabeth
    Barr, Elizabeth
    Pham, Michelle
    Mawlana, Sajeeda
    Supparatpinyo, Khuanchai
    Gatechompol, Sivaporn
    Jalil, Emilia M.
    Gadama, Luis
    Badal-Faesen, Sharlaa
    Belaunzaran-Zamudio, Pablo F.
    Godfrey, Catherine
    Cohn, Susan E.
    Mngqibisa, Rosie
    CONTRACEPTION, 2023, 121
  • [9] Comparison of the Pharmacokinetics of a childfriendly Fixed-Dose Combination of rifampin and isoniazid and separate tablets in children with pulmonary tuberculosis
    Pakhlavonova, Aziza
    Aksenova, Valentina
    Klevno, Nadezhda
    Kazakov, Alexey
    Popov, Sergey
    Hotchenkov, Vyacheslav
    Ruzhitsky, Alexander
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [10] Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia
    Ellis, Jane C.
    L'homme, Rafaella F. A.
    Ewings, Fiona M.
    Mulenga, Veronica
    Bell, Frank
    Chileshe, Regina
    Molyneux, Elizabeth
    Abernethy, Julia
    van Oosterhout, Joep J. G.
    Chintu, Chifumbe
    Walker, A. Sarah
    Gibb, Diana M.
    Burger, David M.
    ANTIVIRAL THERAPY, 2007, 12 (02) : 253 - 260
12